377 related articles for article (PubMed ID: 9352689)
21. Immune inhibitory effects of renal cell carcinoma extract on lectin and alloantigen-induced peripheral blood and tumor infiltrating lymphocyte blastogenesis.
Shabtai M; Ye H; Kono K; Takayam T; Terashima K; Tsukuda K; Frischer Z; Waltzer WC; Malinowski K
Urol Oncol; 2003; 21(1):27-32. PubMed ID: 12684124
[TBL] [Abstract][Full Text] [Related]
22. HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients.
Janssen RA; Buter J; Straatsma E; Heijn AA; Sleijfer DT; de Vries EG; Mulder NH; The TH; de Leij L
Cancer Immunol Immunother; 1993; 36(3):198-204. PubMed ID: 8439981
[TBL] [Abstract][Full Text] [Related]
23. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
Roussel E; Gingras MC; Grimm EA; Roth JA
Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
[TBL] [Abstract][Full Text] [Related]
24. Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes.
Watanabe N; Hizuta A; Tanaka N; Orita K
Clin Exp Immunol; 1995 Oct; 102(1):167-73. PubMed ID: 7554384
[TBL] [Abstract][Full Text] [Related]
25. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Georgiannos SN; Renaut A; Goode AW; Sheaff M
Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T
Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651
[TBL] [Abstract][Full Text] [Related]
28. Helper T cells infiltrating human renal cell carcinomas have the phenotype of activated memory-like T lymphocytes.
Alexander RB; Fitzgerald EB; Mixon A; Carter CS; Jakobsen M; Cohen PA; Rosenberg SA
J Immunother Emphasis Tumor Immunol; 1995 Jan; 17(1):39-46. PubMed ID: 7728304
[TBL] [Abstract][Full Text] [Related]
29. Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma.
Wang QJ; Hanada K; Robbins PF; Li YF; Yang JC
Cancer Res; 2012 Dec; 72(23):6119-29. PubMed ID: 23071066
[TBL] [Abstract][Full Text] [Related]
30. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
Belldegrun A; Tso CL; Kaboo R; Pang S; Pierce W; deKernion JB; Figlin R
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):149-61. PubMed ID: 8732698
[TBL] [Abstract][Full Text] [Related]
31. Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma.
Kim TY; von Eschenbach AC; Filaccio MD; Hayakawa K; Parkinson DR; Balch CM; Itoh K
Cancer Res; 1990 Sep; 50(17):5263-8. PubMed ID: 2143685
[TBL] [Abstract][Full Text] [Related]
32. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes.
Riccobon A; Gunelli R; Ridolfi R; De Paola F; Flamini E; Fiori M; Saltutti C; Petrini M; Fiammenghi L; Stefanelli M; Granato AM; Cuzzocrea DE; Amadori D
Cancer Invest; 2004; 22(6):871-7. PubMed ID: 15641485
[TBL] [Abstract][Full Text] [Related]
34. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes.
Elsässer-Beile U; Grussenmeyer T; Gierschner D; Schmoll B; Schultze-Seemann W; Wetterauer U; Schulte Mönting J
Cancer Immunol Immunother; 1999 Jul; 48(4):204-8. PubMed ID: 10431690
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
36. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
Wu XX; Zeng Y; Jin XH; Kakehi Y
Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
[TBL] [Abstract][Full Text] [Related]
37. [Immunological assessment of tumour infiltrating lymphocyte subsets in renal cell carcinoma patients. An analysis of immunological reaction to immuno-competent lymphocytes by interferon-gamma].
Ohnishi T
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):216-24. PubMed ID: 1904117
[TBL] [Abstract][Full Text] [Related]
38. T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients.
Alam SM; Clark JS; Leech V; Whitford P; George WD; Campbell AM
Immunol Lett; 1992 Feb; 31(3):279-83. PubMed ID: 1347754
[TBL] [Abstract][Full Text] [Related]
39. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
40. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
